Robin Shane Readnour - 29 Mar 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role: Director
Signature: /s/ Lucy Day, Attorney-in-Fact for Robin Shane Readnour
Issuer symbol: ANTX
Transactions as of: 29 Mar 2022
Net transactions value: +$2,300,010
Form type: 4
Filing time: 31 Mar 2022, 20:15:32 UTC
Previous filing: 24 Mar 2022
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ANTX	Common Stock	Conversion of derivative security		+285,156			285,156	29 Mar 2022	See footnotes	F1, F2, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+333,135			333,135	29 Mar 2022	See footnotes	F1, F3, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+61,491	+22%		346,647	29 Mar 2022	See footnotes	F1, F2, F4
transaction	ANTX	Common Stock	Conversion of derivative security		+71,839	+22%		404,974	29 Mar 2022	See footnotes	F1, F3, F4
transaction	ANTX	Common Stock	Purchase	$1,060,740	+70,716	+20%	$15.00	417,363	29 Mar 2022	See footnotes	F2, F4
transaction	ANTX	Common Stock	Purchase	$1,239,270	+82,618	+20%	$15.00	487,592	29 Mar 2022	See footnotes	F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANTX	Series A Convertible Preferred Stock	Conversion of derivative security	$0	-285,156	-100%	$0.000000^*	0	29 Mar 2022	Common Stock	285,156		See footnotes	F1, F2, F4
transaction	ANTX	Series A Convertible Preferred Stock	Conversion of derivative security	$0	-333,135	-100%	$0.000000^*	0	29 Mar 2022	Common Stock	333,135		See footnotes	F1, F3, F4
transaction	ANTX	Series B Convertible Preferred Stock	Conversion of derivative security	$0	-61,491	-100%	$0.000000^*	0	29 Mar 2022	Common Stock	61,491		See footnotes	F1, F2, F4
transaction	ANTX	Series B Convertible Preferred Stock	Conversion of derivative security	$0	-71,839	-100%	$0.000000^*	0	29 Mar 2022	Common Stock	71,839		See footnotes	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
F2	Shares held directly by MGC Venture Partners 2018, LP. ("MGC 2018 LP").
F3	Shares held directly by MGC Venture Partners QP 2018 LP ("MGC 2018 QP").
F4	MGC Venture Partners 2018 GP, LLC ("MGC 2018 GP") is the general partner of MGC 2018 LP and MGC 2018 QP. MGC 2018 GP has shared voting and shared dispositive power over the shares held by MGC 2018 LP and MGC 2018 QP. The Reporting Person is a member of the Issuer's board of directors and is a member of MGC 2018 QP and MGC 2018 LP and a managing partner of MGC 2018 GP and has shared voting power and shared dispositive power over the shares of common stock held by MGC 2018 LP and MGC 2018 QP. The Reporting Person disclaims beneficial ownership of the securities, except to the extent of such person's pecuniary interest in such securities.